Free Trial

Harmony Biosciences (HRMY) SEC Filings & 10K Form

$29.35
-0.84 (-2.78%)
(As of 05/23/2024 ET)

Recent Harmony Biosciences SEC Filings

DateFilerForm TypeView
05/03/2024
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
7:05 AM
Budur Kumar (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2024
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
8:44 AM
Harmony Biosciences (Filer)
Form ARS
04/11/2024
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
7:17 AM
Harmony Biosciences (Filer)
Form DEF 14A
04/11/2024
7:18 AM
Harmony Biosciences (Filer)
Form DEFA14A
03/18/2024
6:24 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:24 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
4:17 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:21 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:16 PM
Harmony Biosciences (Filer)
Form 10-K/A
02/22/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
6:06 PM
Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
Form SC 13G/A
01/08/2024
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
7:59 AM
Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2023
8:03 AM
Anastasiou Peter (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2023
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
7:31 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
10/11/2023
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Harmony Biosciences (Subject)
Form SC 13G/A
10/05/2023
3:15 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
3:15 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:12 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
09/25/2023
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:59 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T/A
09/14/2023
3:42 PM
Harmony Biosciences (Filer)
Form 8-K/A
08/28/2023
7:23 AM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-T
08/24/2023
4:23 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC 13D
08/14/2023
4:26 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-C
08/14/2023
4:27 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
4:29 PM
Harmony Biosciences (Filed by)
Zynerba Pharmaceuticals, Inc. (Subject)
Form SC TO-C
08/01/2023
7:01 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This could mean the end of the U.S dollar… (Ad)

Experts say global conflict and escalated tensions could send the U.S. economy spiraling… Which is why elites and billionaire investors turn to physical precious metals in times like these.

Download your FREE Precious Metals Guide Now.
07/27/2023
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
3:37 PM
Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
Form 4/A
05/26/2023
4:25 PM
Harmony Biosciences (Issuer)
Nielsen Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
3:20 PM
Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
3:26 PM
Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:HRMY) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners